Arcadia Biosciences Stock Today
| RKDA Stock | USD 2.06 0.11 5.64% |
Performance0 of 100
| Odds Of DistressOver 84
|
Arcadia Biosciences is trading at 2.06 as of the 19th of April 2024, a 5.64 percent increase since the beginning of the trading day. The stock's open price was 1.95. Arcadia Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Arcadia Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Food, Beverage & Tobacco | IPO Date 15th of May 2015 | Category Consumer Defensive | Classification Consumer Staples |
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company was incorporated in 2002 and is headquartered in Davis, California. Arcadia Bio operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. The company has 1.36 M outstanding shares of which 3.67 K shares are at this time shorted by private and institutional investors with about 0.18 trading days to cover. More on Arcadia Biosciences
Moving together with Arcadia Stock
| 0.63 | BUD | Anheuser Busch Inbev Financial Report 2nd of May 2024 | PairCorr |
Moving against Arcadia Stock
| 0.79 | TSN | Tyson Foods Financial Report 13th of May 2024 | PairCorr |
| 0.75 | FDP | Fresh Del Monte | PairCorr |
| 0.71 | BG | Bunge Limited Financial Report 1st of May 2024 | PairCorr |
| 0.71 | LSF | Laird SuperfoodInc Financial Report 8th of May 2024 | PairCorr |
| 0.7 | GIS | General Mills Financial Report 26th of June 2024 | PairCorr |
| 0.69 | LMNR | Limoneira Financial Report 4th of June 2024 | PairCorr |
| 0.62 | TPB | Turning Point Brands Financial Report 1st of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 20th of May 2024
Arcadia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arcadia Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arcadia Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Rajendra Ketkar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Agriculture (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Agricultural Products & Services, Food, Beverage & Tobacco, Consumer Defensive, NASDAQ Composite, NASDAQ Composite Total, Agriculture, Consumer Staples, Food Products, Agricultural Inputs, Basic Materials (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Arcadia Biosciences report their recommendations after researching Arcadia Biosciences' financial statements, talking to executives and customers, or listening in on Arcadia Biosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Arcadia Biosciences. The Arcadia consensus assessment is calculated by taking the average forecast from all of the analysts covering Arcadia Biosciences. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Arcadia Biosciences' liquidity, profitability, solvency, and operating efficiency, Arcadia Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Arcadia Biosciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arcadia Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Arcadia Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Arcadia Biosciences' financial leverage. It provides some insight into what part of Arcadia Biosciences' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arcadia Biosciences (RKDA) is traded on NASDAQ Exchange in USA. It is located in 5950 Sherry Lane, Dallas, TX, United States, 75225 and employs 21 people. Arcadia Biosciences is listed under Agricultural Products & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arcadia Biosciences's market, we take the total number of its shares issued and multiply it by Arcadia Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arcadia Biosciences conducts business under Food Products sector and is part of Consumer Staples industry. The entity has 1.36 M outstanding shares of which 3.67 K shares are at this time shorted by private and institutional investors with about 0.18 trading days to cover.
Arcadia Biosciences currently holds about 21.23 M in cash with (15.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check Arcadia Biosciences Probability Of Bankruptcy
Ownership AllocationAlmost 77.0 percent of Arcadia Biosciences outstanding shares are held by general public with 2.59 (percent) owned by insiders and only 20.53 % by other corporate entities.
Check Arcadia Ownership Details
Arcadia Stock Price Odds Analysis
What are Arcadia Biosciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Arcadia Biosciences jumping above the current price in 90 days from now is about 91.07%. The Arcadia Biosciences probability density function shows the probability of Arcadia Biosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Arcadia Biosciences has a beta of 0.5234 indicating as returns on the market go up, Arcadia Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arcadia Biosciences will be expected to be much smaller as well. Additionally, arcadia Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Arcadia Biosciences to move above the current price in 90 days from now is about 91.07 (This Arcadia Biosciences probability density function shows the probability of Arcadia Stock to fall within a particular range of prices over 90 days) .
Arcadia Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Arcadia Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Arcadia Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arcadia Biosciences' value.| Instituion | Recorded On | Shares | |
| Oliver Lagore Vanvalin Investment Group | 2023-12-31 | 4.0 | |
| Royal Bank Of Canada | 2023-12-31 | 2.0 | |
| Harbour Investments, Inc. | 2023-12-31 | 1.0 | |
| Ubs Group Ag | 2023-09-30 | 0.0 | |
| Sabby Management Llc | 2023-12-31 | 97.3 K | |
| Vanguard Group Inc | 2023-12-31 | 14 K | |
| State Street Corporation | 2023-12-31 | 12.1 K | |
| Virtu Financial Llc | 2023-12-31 | 11.4 K | |
| Tower Research Capital Llc | 2023-12-31 | 2.9 K | |
| Jpmorgan Chase & Co | 2023-12-31 | 508 | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 207 |
Arcadia Biosciences Historical Income Statement
Arcadia Biosciences Income Statement is one of the three primary financial statements used for reporting Arcadia's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Arcadia Biosciences revenue and expense. Arcadia Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Arcadia Biosciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 6 M, whereas Interest Expense is forecasted to decline to about 247.1 K. View More FundamentalsArcadia Stock Against Markets
Picking the right benchmark for Arcadia Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Arcadia Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Arcadia Biosciences is critical whether you are bullish or bearish towards Arcadia Biosciences at a given time. Please also check how Arcadia Biosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Arcadia Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Arcadia Biosciences Corporate Directors
Arcadia Biosciences corporate directors refer to members of an Arcadia Biosciences board of directors. The board of directors generally takes responsibility for the Arcadia Biosciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arcadia Biosciences' board members must vote for the resolution. The Arcadia Biosciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Uday Garg | Independent Director | Profile | |
| Peter Gajdos | Director | Profile | |
| Gregory Waller | Director | Profile | |
| George Gosbee | Director Nominee | Profile |
How to buy Arcadia Stock?
Before investing in Arcadia Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Arcadia Biosciences. To buy Arcadia Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Arcadia Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Arcadia Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Arcadia Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Arcadia Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Arcadia Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Arcadia Stock please use our How to Invest in Arcadia Biosciences guide.
Already Invested in Arcadia Biosciences?
The danger of trading Arcadia Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arcadia Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arcadia Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arcadia Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.Note that the Arcadia Biosciences information on this page should be used as a complementary analysis to other Arcadia Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Arcadia Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (10.64) | Revenue Per Share 4.309 | Quarterly Revenue Growth 0.573 | Return On Assets (0.34) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.